Toronto Dominion Bank trimmed its holdings in Colgate-Palmolive (NYSE:CL) by 96.0% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 31,351 shares of the company’s stock after selling 761,940 shares during the quarter. Toronto Dominion Bank’s holdings in Colgate-Palmolive were worth $46,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds and other institutional investors have also modified their holdings of the business. Massachusetts Financial Services Co. MA lifted its holdings in Colgate-Palmolive by 5.0% in the 1st quarter. Massachusetts Financial Services Co. MA now owns 35,125,475 shares of the company’s stock valued at $2,330,928,000 after acquiring an additional 1,686,475 shares during the last quarter. Wellington Management Group LLP lifted its stake in Colgate-Palmolive by 3.4% during the first quarter. Wellington Management Group LLP now owns 26,602,342 shares of the company’s stock valued at $1,765,333,000 after buying an additional 863,629 shares in the last quarter. Bank of New York Mellon Corp lifted its stake in Colgate-Palmolive by 2.0% during the first quarter. Bank of New York Mellon Corp now owns 18,597,340 shares of the company’s stock valued at $1,234,119,000 after buying an additional 356,819 shares in the last quarter. Geode Capital Management LLC lifted its stake in Colgate-Palmolive by 2.8% during the first quarter. Geode Capital Management LLC now owns 14,186,086 shares of the company’s stock valued at $940,015,000 after buying an additional 385,666 shares in the last quarter. Finally, Capital World Investors purchased a new stake in Colgate-Palmolive during the first quarter valued at about $829,740,000. 77.13% of the stock is owned by institutional investors.
In other Colgate-Palmolive news, CTO Patricia Verduin sold 42,775 shares of the stock in a transaction that occurred on Wednesday, August 5th. The stock was sold at an average price of $76.52, for a total transaction of $3,273,143.00. Following the transaction, the chief technology officer now owns 89,800 shares in the company, valued at $6,871,496. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, SVP John J. Huston sold 84,905 shares of the stock in a transaction that occurred on Wednesday, August 12th. The shares were sold at an average price of $77.18, for a total value of $6,552,967.90. Following the transaction, the senior vice president now owns 82,988 shares in the company, valued at approximately $6,405,013.84. The disclosure for this sale can be found here. Insiders sold 256,206 shares of company stock worth $19,617,943 in the last 90 days. 0.78% of the stock is currently owned by corporate insiders.
NYSE:CL traded up $0.17 during mid-day trading on Thursday, reaching $78.12. The stock had a trading volume of 106,293 shares, compared to its average volume of 3,447,267. The business’s 50 day moving average is $75.18 and its 200 day moving average is $72.07. Colgate-Palmolive has a fifty-two week low of $58.49 and a fifty-two week high of $78.19. The stock has a market cap of $66.58 billion, a P/E ratio of 26.16, a PEG ratio of 4.46 and a beta of 0.61. The company has a debt-to-equity ratio of 9.40, a current ratio of 0.92 and a quick ratio of 0.59.
Colgate-Palmolive (NYSE:CL) last released its quarterly earnings data on Friday, July 31st. The company reported $0.74 EPS for the quarter, topping analysts’ consensus estimates of $0.69 by $0.05. Colgate-Palmolive had a return on equity of 559.34% and a net margin of 16.13%. The firm had revenue of $3.90 billion for the quarter, compared to the consensus estimate of $3.78 billion. During the same quarter in the prior year, the company posted $0.72 earnings per share. The firm’s revenue was up .8% on a year-over-year basis. Equities analysts expect that Colgate-Palmolive will post 2.96 EPS for the current year.
The company also recently disclosed a quarterly dividend, which was paid on Friday, August 14th. Investors of record on Monday, July 20th were issued a $0.44 dividend. The ex-dividend date was Friday, July 17th. This represents a $1.76 dividend on an annualized basis and a yield of 2.25%. Colgate-Palmolive’s dividend payout ratio is currently 62.19%.
CL has been the subject of a number of analyst reports. Morgan Stanley upped their price objective on shares of Colgate-Palmolive from $78.00 to $80.00 and gave the company an “equal weight” rating in a research note on Monday, August 3rd. TheStreet raised shares of Colgate-Palmolive from a “c+” rating to a “b+” rating in a research note on Friday, July 31st. Credit Suisse Group reaffirmed a “sell” rating and set a $67.00 price objective on shares of Colgate-Palmolive in a research note on Monday, May 4th. SunTrust Banks increased their price target on shares of Colgate-Palmolive from $75.00 to $80.00 and gave the stock a “buy” rating in a research report on Friday, May 15th. Finally, Stifel Nicolaus increased their price target on shares of Colgate-Palmolive from $72.00 to $75.00 and gave the stock a “buy” rating in a research report on Monday, May 4th. Three analysts have rated the stock with a sell rating, five have assigned a hold rating and six have given a buy rating to the company’s stock. Colgate-Palmolive presently has a consensus rating of “Hold” and an average price target of $75.33.
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. It offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; and personal care products, such as liquid hand soaps, bar soaps, shower gels, deodorants and antiperspirants, skin care products, and shampoos and conditioners.
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.